TANG CAPITAL MANAGEMENT LLC Q3 2018 Filing

Filed November 14, 2018

Portfolio Value

$612.5B

Holdings

4

Report Date

Q3 2018

Filing Type

13F-HR

All Holdings (4 positions)

#StockSharesValue% PortfolioType
1
—ODONATE THERAPEUTICS INC
13,796,747$267.8B43.72%
2
HRTXHERON THERAPEUTICS INC
5,950,826$188.3B30.75%
3
—LA JOLLA PHARMACEUTICAL CO
4,138,893$83.3B13.60%
4
RCKTROCKET PHARMACEUTICALS INC
2,965,485$73.0B11.92%